Fortis Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Fortis Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-524	Closed	-$261K	–	181
2025 Q1	$261K	Sell	524 -694	-57%	-$376K	0.05%	129
2024 Q4	$633K	Sell	1,218 -381	-24%	-$209K	0.12%	90
2024 Q3	$989K	Buy	1,599 +80	+5%	+$47.4K	0.2%	76
2024 Q2	$840K	Sell	1,519 -5,963	-80%	-$3.42M	0.18%	80
2024 Q1	$4.35M	Buy	7,482 +811	+12%	+$455K	1.14%	16
2023 Q4	$3.54M	Buy	6,671 +432	+7%	+$209K	0.91%	21
2023 Q3	$3.16M	Buy	6,239 +4,546	+269%	+$2.42M	0.98%	21
2023 Q2	$883K	Buy	1,693 +119	+8%	+$64.2K	0.31%	58
2023 Q1	$907K	Buy	1,574 +265	+20%	+$149K	0.37%	51
2022 Q4	$721K	Sell	1,309 -44	-3%	-$23.3K	0.53%	45
2022 Q3	$686K	Buy	+1,353	New	+$757K	0.59%	50
2021 Q4	–	Sell	-3,332	Closed	-$1.9M	–	109
2021 Q3	$1.9M	Sell	3,332 -900	-21%	-$494K	1.01%	39
2021 Q2	$2.13M	Hold	4,232	–	–	1.09%	43
2021 Q1	$1.93M	Buy	+4,232	New	+$2.02M	1.11%	55

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fortis Capital Management's TMO Position: Q2 2025 in Review

Fortis Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 524 shares — an estimated $261K sold.

Fortis Capital Management first reported a position in TMO in Q1 2021 and held it in 14 quarters. The position peaked at $4.35M in Q1 2024. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Fortis Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Fortis Capital Management sold 524 Thermo Fisher Scientific shares in Q2 2025, an estimated $261K.
Fortis Capital Management first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 14 quarters.
Fortis Capital Management's Thermo Fisher Scientific position peaked at $4.35M in Q1 2024.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Fortis Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.